These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2864150)

  • 1. The role of stress and the sympathetic nervous system in hypertension and ischemic heart disease: advantages of therapy with beta-receptor blockers.
    DeQuattro V; Hamad R
    Clin Exp Hypertens A; 1985; 7(7):907-32. PubMed ID: 2864150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.
    Dellsperger KC; Martins JB; Clothier JL; Marcus ML
    Circulation; 1990 Sep; 82(3):941-50. PubMed ID: 1975521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural and psychologic mechanisms and the problem of sudden cardiac death.
    Lown B; Verrier RL; Rabinowitz SH
    Am J Cardiol; 1977 May; 39(6):890-902. PubMed ID: 860697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.
    Podrid PJ; Fuchs T; Candinas R
    Circulation; 1990 Aug; 82(2 Suppl):I103-13. PubMed ID: 1973640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of ischaemic heart disease in the hypertensive patient.
    Thomas M
    Adv Cardiol; 1982; 31():95-7. PubMed ID: 6129787
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive therapy--going to the heart of the matter.
    Messerli FH
    Circulation; 1990 Mar; 81(3):1128-35. PubMed ID: 1968365
    [No Abstract]   [Full Text] [Related]  

  • 10. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hypertension: left ventricular mass and function, sympathetic nervous system activity, and therapy.
    DeQuattro V; Lee DD; Shkhvatsabaya IK; Yurenev AP; Salenko BB; Allen J; Azen S; Barndt R; Foti A; Davison G
    Health Psychol; 1988; 7 Suppl():165-73. PubMed ID: 2977327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta receptor blockade in preventing sudden death.
    Wikstrand J; Kendall M
    Eur Heart J; 1992 Sep; 13 Suppl D():111-20. PubMed ID: 1356781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Silent ischemia,' ventricular arrhythmias, and complications of hypertension.
    Devereux RB
    Circulation; 1992 May; 85(5):1948-50. PubMed ID: 1533353
    [No Abstract]   [Full Text] [Related]  

  • 14. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension.
    Esler M
    Exp Physiol; 2011 Jul; 96(7):611-22. PubMed ID: 21551268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.
    Borhani NO
    Am J Cardiol; 1987 Dec; 60(17):13I-18I. PubMed ID: 2961245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypertension and cardiovascular risk.
    Hollenberg NK
    Am J Med; 1991 Feb; 90(2A):2S-6S. PubMed ID: 1671628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
    Johns VJ
    Am J Surg; 1984 Jun; 147(6):725-30. PubMed ID: 6145367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy resulting from systemic hypertension: adaptive advantage and adverse consequences.
    Taylor AL
    J Assoc Acad Minor Phys; 1991; 2(4):156-61. PubMed ID: 1839825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.